Workflow
君正集团(601216) - 2021 Q1 - 季度财报
JUNZHENGJUNZHENG(SH:601216)2021-04-29 16:00

Financial Performance - Operating revenue for the period was ¥4,075,021,582.86, representing a year-on-year growth of 14.42%[4] - Net profit attributable to shareholders was ¥1,104,432,265.60, a significant increase of 75.54% compared to the same period last year[4] - Basic earnings per share rose to ¥0.1309, reflecting a 75.47% increase year-on-year[4] - The weighted average return on equity increased by 1.91 percentage points to 5.18%[4] - Total operating revenue for Q1 2021 was CNY 4,075,873,091.99, an increase of 14.4% compared to CNY 3,563,671,711.08 in Q1 2020[28] - The total operating profit for Q1 2021 was CNY 1,298,824,837.51, an increase of 77.5% compared to CNY 732,664,402.07 in Q1 2020[30] - The net profit attributable to shareholders of the parent company reached CNY 1,104,432,265.60, up 75.3% from CNY 629,146,567.91 in the same period last year[31] - The comprehensive income totalled CNY 1,109,160,911.22, representing a 60.9% increase from CNY 688,093,446.87 in Q1 2020[32] Assets and Liabilities - Total assets at the end of the reporting period reached ¥36,368,559,450.10, an increase of 7.98% compared to the end of the previous year[4] - The total current assets amounted to RMB 9,491,707,157.80, a decrease from RMB 10,292,634,518.82 as of December 31, 2020[19] - The total non-current assets increased to RMB 26,876,852,292.30 as of March 31, 2021, compared to RMB 23,387,513,705.27 at the end of 2020[21] - Current liabilities decreased to RMB 8,854,986,881.90 as of March 31, 2021, from RMB 9,322,613,135.56 at the end of 2020[21] - The total liabilities increased to CNY 14,046,542,680.81 in Q1 2021 from CNY 12,476,474,871.58 in the previous year, representing a growth of approximately 12.6%[23] - The total liabilities increased from ¥12,476,474,871.58 to ¥15,427,404,103.90, showing an adjustment of ¥2,950,929,232.32[47] Cash Flow - The net cash flow from operating activities decreased by 61.53% to ¥83,758,798.41 compared to the previous year[4] - Net cash flow from investing activities decreased by 86.72% to ¥1,317,274,271.32, mainly due to the previous year's receipt of performance guarantees related to share transfers[13] - In Q1 2021, the cash inflow from operating activities was CNY 2,441,524,602.17, a decrease of 5.6% compared to CNY 2,586,571,081.83 in Q1 2020[38] - The net cash flow from investment activities was CNY 1,317,274,271.32 in Q1 2021, compared to CNY 9,919,061,164.24 in Q1 2020, indicating a decline of 86.7%[39] - The net increase in cash and cash equivalents for Q1 2021 was CNY 211,917,244.15, compared to CNY 7,281,975,113.40 in Q1 2020, reflecting a significant decline[39] Shareholder Information - The total number of shareholders at the end of the reporting period was 384,752, with the largest shareholder holding 31.95% of the shares[7] - The company has a significant portion of shares pledged, with the largest shareholder having 1,663,388,767 shares under pledge[7] Investments and Acquisitions - The company is in the process of transferring 283,529,047 shares of Huatai Insurance, representing 7.05% of total shares, to Ande Tianping at a total price of ¥3,402,348,564.00[14] - The transaction price for the acquisition of 100% equity of Shanghai Bosen was set at RMB 457,757,500, based on a valuation of RMB 506,960,000, after adjustments[16] - Lhasa Shengtai subscribed to an increase in registered capital of Hebei Daan Pharmaceutical Co., Ltd. for a total investment of RMB 1,121,998,700, accounting for 31.17% of the increased registered capital[15] Operational Costs - Total operating costs for Q1 2021 were CNY 3,002,341,517.65, up from CNY 2,951,791,925.12 in Q1 2020, reflecting a growth of 1.0%[28] - Sales expenses decreased by 82.39% to ¥18,664,999.99, mainly due to the reclassification of transportation costs related to product sales as operating costs[12] - Financial expenses decreased by 62.30% to ¥40,797,158.85, primarily due to increased exchange gains from currency fluctuations[12] Research and Development - The company reported a research and development expense of CNY 28,904,333.37 for Q1 2021, compared to CNY 24,644,270.09 in Q1 2020, indicating an increase of 17.4%[29] Taxation - The company reported an increase in income tax expenses by 74.21% to ¥176,402,447.85, due to an increase in total profit[12] - The cash paid for taxes in Q1 2021 was CNY 689,872,845.02, which is a 82.4% increase from CNY 379,642,858.20 in Q1 2020[38]